Allergic Skin Reaction
8
1
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (8)
Phleum Pratense and Dactylis Glomerata Allergen Extracts Standardization
Determination of Blomia Tropicalis Allergen Extract in Prick Test Units
Quercus Ilex and Quercus Robur Allergen Extracts Standardisation
SPT for Sensitization of Collagen Dressing
Juniperus Oxycedrus and Cupressus Arizonica Allergen Extracts Standardisation.
Skin Adverse Reactions Occuring in Children Treated by Biotherapy for Chronic Inflammatory Disease
Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP)
The Effect of Medical Clowns and Topical Anesthetic Cream on Pain and Anxiety in Children Undergoing Allergy Skin Tests